A MAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers and PHN Patients.

Clinical trial NCT06218784 · UNKNOWN

Trial details

NCT number: NCT06218784
Sponsor: iN Therapeutics Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Post Herpetic Neuralgia Pain Osteoarthritis Neuropathic Pain Chronic Pain Dorsal Root Ganglion Nav 1.7

Start date: 2022-11-11
Primary completion: 2024-07-29
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.